Heres a breakdown comparing mechanisms, safety, and results of practical use to illustrate when peptides have a clear advantage and when traditional drugs still have a place
Semaglutide requires weekly injections and often causes gastrointestinal side effects, while AOD-9604 is generally well-tolerated with minimal digestive impact
Research use therefore focuses on mechanism, target validation, and combinatorial experiments (e.g., with dietary change or NAD precursors) [14,8,9]
Koi Peptides meets each of those criteria for BPC-157 sourcing, which is why it leads the Canadian research supplier list for 2026
Remarkably, the same narrow dose range proves effective whether counteracting dopamine depletion, serotonin syndrome, glutamate excitotoxicity, or GABA tolerance
benefits Bioglutide (NA-931) Benefits: Oral, No Muscle Loss Bioglutide (NA-931) is oral, once-daily